Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: Potential for endemic and epidemic Kaposi's sarcoma

Journal of Medical Virology

Volumn 82, Issue 7, 2010, Pages 1216-1223

  Caterino de Araujo, Adele ^a,b   Manuel, Rolanda Carmen Rafael ^c   Del Bianco, Rosana ^d   Santos Fortuna, Elizabeth ^a   Magri, Mariana Cavalheiro ^a,b   Silva, Joyce Matie Kinoshita ^a   Bastos, Rui ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d Reference Center in STD Aids   (Brazil)

Author keywords

Epidemiology; HIV; Human herpesvirus 8 (HHV 8); Risk factors; Serology

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; ENDEMIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; SEROPREVALENCE; SIBLING; SOCIOECONOMICS; AGED; BLOOD; DISEASE OUTBREAKS; HEALTH CENTER; HERPESVIRIDAE INFECTIONS; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; SARCOMA, KAPOSI;

HUMAN HERPESVIRUS 8;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH CENTERS; DISEASE OUTBREAKS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; MOZAMBIQUE; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

EID: 77954421871     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21789     Document Type: Article

References (26)

1. Cassol E, Page T, Mosam A, Friedland G, Jack C, Lalloo U, Kopetka J, Patterson B, Esterhuizen T, Coovadia HM. 2005. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or Human herpesvirus-8. J Infect Dis 191:324-332.
2. Caterino-de-Araujo A. 2007. The fight against Kaposi's sarcoma in AIDS - Lessons from Brazil. South Afr J HIV Med 26:53-54.
3. Caterino-de-Araujo A, Manuel RCR, Del Bianco R, Santos-Fortuna E, MagriMC, Silva JMK, Bastos R. 2009. First survey for detecting the presence of human herpesvirus 8 infection (HHV-8) in Maputo, Mozambique. Braz J Infect Dis 13:200-202.
4. Ceffa S, Buonomo E, Altan AM, Erba F, Germano P, Guidotti G, Liotta G, Magnano San Lio M, Scarcella P, Palombi L, Marazzi MC. 2007. Seroprevalence of HHV-8 in a cohort of HIV-negative and HIV-positive patients in Mozambique. Ann Ig 19:519-523.
5. Cunha AMG, Caterino-de-Araujo A, Costa SCB, Santos-Fortuna E, Boa-Sorte NCA, Gonçalves MS, Costa FF, Galvão-Castro B. 2005. Increasing seroprevalence of Human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86:2433-2437.
6. Dedicoat M, Newton R. 2003. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 88:1-3. (Pubitemid 36241209)
7. DeSantis SM, Pau CP, Archibald LK, Nwanyanwu OC, Kazembe PN, Dobbie H, Jarvis WR, Jason J. 2002. Demographic and immune correlates of human herpesvirus 8 seropositivity in Malawi, Africa. Int J Infect Dis 6:266-271.
8. Edelman DC. 2005. Human herpesvirus 8: A novel human pathogen. Virol J 2:1-91.
9. Flanigan TP, Campbell T, Harwell J, Kumarasamy N. 2005. The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or Kaposi sarcoma!). J Infect Dis 191:321-323. (Pubitemid 40139755)
10. Hengee UR, Ruzicka T, Tyring SK, Seeber S. 2002. Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part. 1: Epidemiology, environmental predispositions, and therapy. Lancet Infect Dis 2:281-292.
11. Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C. 2005. Epidemiological characteristics of human herpsvirus- 8 infectio in a large population of antenatal women in Zambia. J Med Virol 75:93-100. (Pubitemid 39578795)
12. Mbulaiteye SM, Pfeifer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. 2003. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 187:1780-1785. (Pubitemid 36667889)
13. Mbulaiteye SM, Biggar RJ, Pfeifer RM, Bakaki PM, Gamache C, Owor AM, Katongole-Mbidde E, Ndugwa CM, Goedert JJ, Whitby D, Engels EA. 2005. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 38:474-479.
14. Ministério da Saú de. 2006. Repú blica de Moçambique. Relatório Anual 2006. PNC ITS/HIV/SIDA - Aconselhamento e Testagem em Saú de.
15. Ministério da Saú de. 2007. Repú blica de Moçambique. Boletim DNAM - Direcção Nacional de Assistência Médica, No 2 - Vol. III. Julho 2007.
16. Mohanna S, Portillo JA, Carriquiry G, Vidal J, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E. 2007. Human herpesvirus-8 in Peruvian blood donors: A population with hyperendemic disease? Clin Infect Dis 44:558-561.
17. Moore PS, Chang Y. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332:1181-1185.
18. Nascimento MC, Souza VA, Sumita LM, Freire W, Weiss H, Sabino EC, Franceschi S, Panutti CS, Mayaud P. 2008. Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: A multi-center serosurvey. J Med Virol 80:1202-1210.
19. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group. 2003. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer 103:226-232.
20. Plancoulaine S, Abel L, Trégouët D, Duprez R, van Beveren M, Tortevoye P, Froment A, Gessain A. 2004. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody level in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res 64:8782-8787.
21. Silva JMK, Magri MC, Jacob F, Santos-Fortuna E, Caterino-de-Araujo A. 2007. Otimização e avaliação do ensaio de imunofluorescência indireta para pesquisa de anticorpos anti-herpesv?́rus humano 8 (HHV-8) usando sangue colhido em papel de filtro. Rev Inst Adolfo Lutz 6:68-72.
22. Sissolak G, Mayaud P. 2005. AIDS-related Kaposi's sarcoma: Epidemiological, diagnostic, treatment and control aspects in sub- Saharan Africa. Trop Med Int Health 10:981-992.
23. Sitas F, Newton R. 2000. Kaposi's sarcoma in South Africa. J Natl Cancer Inst Monogr 28:1-4.
24. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R. 1999. Antibodies against human herpesvirus 8 in black south African patients with cancer. N Engl J Med 340:1863-1871.
25. Szajerka T, Jablecki J. 2007. Kaposi's sarcoma revisited. Aids Rev 9:230-236.
26. Wojcicki JM, Newton R, Urban MI, Stein L, Hale M, Patel M, Ruff P, Sur R, Bourboulia D, Sitas F. 2004. Low socioeconomic status and risk for infection with human herpesvirus 8 among HIV-1 negative, South African black cancer patients. Epidemiol Infect 132:1191-1197.